Starting HIV prevention pills in jail
This program helps people in jail start PrEP, a daily pill that prevents HIV. It is for inmates who are interested in PrEP and have recently used drugs or alcohol heavily. The goal is to start PrEP while still incarcerated and continue after release.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in jail or prison (at the Rhode Island Department of Corrections).
- You are at least 18 years old.
- You are not pregnant right now.
- You are eligible for PrEP (the daily HIV prevention pill).
- You have not taken PrEP in the 3 months before you were locked up.
- You are interested in starting PrEP.
- In the 3 months before jail, you used illegal drugs or had a heavy drinking day.
- You expect to stay in jail for more than a week but less than 6 months.
- You can speak and understand English well enough to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study checks whether taking HIV prevention medicine called PrEP can help protect people who are not living with HIV but have recent risk of HIV exposure. You may qualify if you have ongoing risk and are not already taking PrEP.
This trial helps people recently involved with the justice system and who use stimulants or opioids decide on HIV prevention or treatment. It tests a shared decision-making approach for taking HIV medication (ART) or PrEP.
This study helps people who inject drugs start HIV prevention (PrEP) and medication for opioid use disorder (MOUD) faster. It may reduce HIV risk and improve access to treatment, while the study checks whether the “rapid access” approach works.
This study tests a program to help men who recently left prison and use injectable drugs start and stick with PrEP, a daily pill that prevents HIV. It aims to improve health and connect them with care.
Hear when a new HIV Prevention Program trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.